Restenosis after angioplasty is a significant clinical problem. 1 A dominant cellular event is the renarrowing of the vascular lumen after angioplasty, which is due to vascular smooth muscle cell (VSMC) proliferation and migration. After injury, VSMCs proliferate and then migrate into the developing neointima to become the major cellular substrate of restenotic tissue. 2 The pathogenesis of neointimal formation is mediated by VSMCs through phenotype transformation, proliferation, migration, and extracellular matrix rearrangement. Thus, suppressing VSMC proliferation has therapeutic potential for reducing the incidence of occlusive vascular diseases.
2 Vascular injuries release pathological mediators from activated platelets, including platelet-derived growth factor (PDGF), which plays an important role in forming the neointima and, ultimately, in restenosis.
3,4 PDGF expression is high in injured arteries and correlates with neointimal cellular proliferation.
3 PDGF activates intracellular signal transduction pathways that contribute to VSMC proliferation, and the role of PDGF in neointima development has been evaluated in arterial injury models.
5 Thus, inhibiting PDGF-induced VSMC proliferation may provide a therapeutic approach to attenuate the cellular manifestation of vascular disease. Cell proliferation is regulated by many factors during the cell cycle, including cyclin-dependent kinase (cdk) and cyclin family genes, a major group of cell cycle regulatory proteins that regulate cdk activity.
6 Of these, cyclin D1 is a key regulator and marker of cell proliferation, subject to both transcriptional and post-transcriptional regulation.
7
Wisteria floribunda (Leguminosae) is widely grown in East Asian countries. Its gall extracts are used as an antitumoral preparation in traditional Oriental medicine.
8 Many Oriental medicinists used W. floribunda gall extracts for treating patients with breast cancer, stomach cancer, and rheumatoid arthritis. Extracts and isolated compounds from the flowers and seeds of W. floribunda also have antioxidant, anticancer, and immunological activities.
8,9
The methanol extracts of the W. floribunda fruit peels showed significant positive activity in a preliminary study in which we screened plant extracts with an inhibitory effect on PDGF-induced VSMC proliferation. To clarify the active components causing this inhibition, a methanol extract of the fruit peels was subjected to various separation procedures. Resulting, 21 compounds were isolated from fruit peels of W. floribunda (Fig. 1) . Their structures were identified by comparing physicochemical and spectroscopic data to published values for lupeol (1),
12 taraxerone (4), 13 taraxerol (5), 13 3,4-dimethoxy benzaldehyde (6), 14 syringaresinol (7),
28 Among them, 13 compounds (9-21) were flavonoids, five compounds (1-5) were triterpenoids, two compounds (7, 8) were lignans, and one compound (6) was phenyl derivatives. This is the first report on a chemical investigation of W. floribunda fruit peels.
Next, the isolated compounds were evaluated for their ability to inhibit PDGF-induced VSMC proliferation using a BrdU incorporation assay. Compounds 1, 4, 9, 12, 13, and 15 showed the highest inhibitory effects, with IC 50 values (µM) of 5.4, 7.5, 6.7, 4.3, 4.6, and 3.6, respectively (Table  1) . Compounds 3, 5-7, and 10 were weak active (IC 50 > 50 µM). The remaining compounds exhibited modest inhibitory effects (IC 50 s in the range 19.3-46.6 µM). Juglone, IC 50 2.4 µM, was used as positive control. The compounds showed no significant cytotoxicity up to 50 µM in the MTT assay suggesting that our results were not due to cytotoxic effects. Cyclin D1 promotes cell growth and its expression is induced by growth factor stimulation. 29 Thus, to examine the underlying mechanism of the anti-proliferative effect exerta These authors contributed equally to this work.
Notes
ed by the isolated compounds, we tested them on cyclin D1 expression using Western blotting assay. PDGF significantly increased cyclin D1 expression, and pretreatment with the compound suppressed this increase, as observed by lower intensities band. At a concentration of 10 µM, compounds 1, 4, 9, 12, 13, and 15 showed inhibitory effects on PDGFinduced cyclin D1 expression in VSMCs (Fig. 2) .
Bioassay showed that triterpenoids containing a taraxer-14-en skeleton with a 3-ketone functional group (4), exhibited a stronger effect than did triterpenoids with a 3-alcohol functional group (5). This result may be associated with the electrostatic interaction ability of compound 4 at position 3 compared with that of 5. Kaempferol (15) , which contains free hydroxyl groups, showed good activity compared with its glycosides. Among the flavan-3-ols, catechin (12) and epicatechin (13) produced strong effects compared with afzelechin (11) and epiafzelechin (9), suggesting an increased activity role for the additional hydroxyl group in the B-ring. The results also showed a difference between configurations; the 2R,3S-configuration (9, 12) may have more efficacy than the 2R,3R-configuration (11, 13) .
In conclusion, the chemical constituents of W. floribunda were studied, and flavonoids, triterpenoids and lignans were isolated from fruit peels extracts. The effects of the isolated compounds on PDGF-induced VSMC proliferation were Extraction and Isolation. Dried samples (6 kg) were pulverized and extracted with 95% methanol (18 L) under reflux for 3 × 6 h. The extract was concentrated to dryness under reduced pressure. The residue was suspended in water and partitioned sequentially with hexane, ethyl acetate, and butanol. The crude extracts were subjected to various column chromatography procedures on silica gel, YMC RP- Cell Culture. VSMCs were isolated from rat thoracic aorta, as described previously.
30 Individual cells were placed in a culture dish and grown in DMEM containing 10% fetal bovine serum (FBS). Cells were passaged by trypsinization, and passages 5-12 were used for experiments.
Cell Viability Assay. Cells were seeded in 96-well plates at a density of 2 × 10 4 cells/well and cultured for 24 h. After a 48 h incubation of the cells with different concentrations of the test compounds, the cytotoxicity of the compounds was determined by the MTT assay, as described previously.
31
Percent cell viability was calculated based on the absorbance measured relative to the absorbance of control cells exposed to the vehicle alone.
5-Bromo-2'-deoxy-uridine (BrdU) Assay Viable adherent cells were incubated with BrdU labeling solution (10 μM) for 2 h. Cells were fixed in a fixation solution for 30 min at room temperature and incubated with 100 μL anti-BrdU peroxidase-labeled antibody for 90 min. After three washes, substrate solution for colorimetric quantification was added at a final concentration of 100 μL/mL and maintained at room temperature for 5-30 min until color development was sufficient for photometric detection. Absorbance was assayed at 405 nm.
Western Blot Analysis. The cells were collected and washed with phosphate-buffered saline (PBS). The harvested cells were then lysed on ice for 30 min in 100 μL lysis buffer (120 mM NaCl, 40 mM Tris, pH 8, 0.1% Nonidet P-40) and centrifuged (12,000 rpm, 30 min). Supernatants were collected from the lysates and protein concentrations were determined using the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Aliquots of the lysates (40 μg of protein) were boiled for 5 min and electrophoresed on 10% SDSpolyacrylamide gels. Proteins in the gels were transferred onto nitrocellulose membranes, which were then incubated with cyclin D1 or mouse monoclonal β-actin antibodies. The membranes were further incubated with secondary antimouse or anti-rabbit antibodies. Finally, protein bands were detected using the Enhanced Chemiluminescence Western Blotting Detections Kit (Pierce Biotechnology, Rockford, IL, USA).
Statistical Analyses. Experimental results are expressed as means ± SD. A one-way analysis of variance was used for multiple comparisons followed by Dunnett's test. Differences with a P < 0.05 were considered statistically significant.
